text:
Intel Lava XOLO X900 gets Ice Cream Sandwich update
- Nitin Rinkesh
> In reply to archana @ 2014-01-30 08:28 from utp3 - click to readbut someone told me its brilliant phone and works good.
what issues do you have with this phone ?
- 2014-02-22 17:42
- wiSe
- archana
please please please do not buy xolo product. Instead of having intel's name attached to it, it is great mess. having hell problems occuring one after other and no one cares for attending it.
- 2014-01-30 08:28
- utp3
- Gaur
This is bloody shit phone.. Have issues with network connectivity and supported with Shit customer service.. Please please please don't buy Xolo at all.. I have used this phone for 6 months and screwed at best
- 2013-12-10 18:28
- sSR8
- Sageer
Donate your money rather than buying xolo phone
- 2013-11-19 07:16
- rJK{
- rajoopradhan
This is how the mobile company `Xolo Lava` has been taking their customers for a ride.
I bought a Intel Xolo X 900 Black from H. K. Mobiles in Mumbai for Rs.22,000/-. In 3 months it has had two problems. Its auto rotate system stopped working. Occasionally for 3-4 days in a fortnight I couldnt be heard by person on the other end. Initially I thought it was a service providers problem. As the problem persisted for about two months, I lodged a complaint with the service centre. (Notification No. 310000028601 dt. 01/04/2013) The phone was picked up & returned in fortnights time. The problem was not solved.
2nd complaint was made (Notification No. 310000036261 dt. 17/04/2013).The phone was picked up and returned on 04/05/2013) the problem was not solved.
3rd complaint was made (Notification No. 310000054458 dt. 07/05/2013). The phone was picked up and returned on 03/06/2013) the problem remained unsolved.
The 4th complaint was made (Notification No. 310000065765 dt. 03/06/2013). The phone was picked up and not returned till date.
The entire experience is extremely bad. Talking to Xolo customer care is so futile that you can always be sure that nothing positive can come out talking to the staff. The customer care and service centre seem to be entirely disconnected.
I have made umpteen no. of communication for refund of money which once or twice they agreed but money they were ready to pay was Rs.10,000/- as against Rs.22,000/- On couple of occasions they said they can give me a replacement of LAVA mobile which is costing around Rs.7,000/- in the market. If you do not accept these refund or replacement options from them; you can be sure that nothing will arrive, no refund, no replacement and no communication.
Generally most corporates are conscientious and work with some philosophy. There are others who behave good because there are laws. But there are companies like Lava which exist only to take their customers for a ride.
Rajoo Pradhan
- 2013-11-08 09:10
- 2@t@
- Abhi
> In reply to Ranka @ 2013-10-07 14:06 from 2SQq - click to read i bought x900, display cracked and i'm still suffering bCoz company has not released LCD display yet..isn't it ridiculous.., pls help
- 2013-10-20 05:45
- XuNh
- Mithun
don't buy xolo at all, customer service is the worst..
i bought x900, display cracked and i'm still suffering bCoz company has not released LCD display yet..isn't it ridiculous..
- 2013-10-07 18:57
- uuS$
- Ranka
If any body wants to file complain with Consumer court, kindly contact me as i am going to file the same.
- 2013-10-07 14:06
- 2SQq
- naspro
im suffering with this xolo x900 just one week of usage and im in trouble
- 2013-10-06 14:58
- KhtM
- Ranka
Dear Friends,
Dont buy any mobile of xolo otherwise you will loose your money as there is no service , no technology etc.
I am suffering from the date of purchase and after all now i am going to fight through consumer forum only.
As I have given my mobile 3 times for repair in 6 month of purchase and they take 20 days minimum to repair and afterwards it works more worst.
- 2013-09-28 07:39
- Abhi
Xolo has worst types of mobile in the world,.... I Appeal to all Visitors on this site and request to all..... That never think to buy xolo mobile otherwise you will lost your money and afterwards nobody will help you and at the end you will have to fight through consumer forum as i am doing.
- 2013-09-28 07:34
- mahesh/maheshpatel28
> In reply to GOKU @ 2013-06-12 11:53 from t}CJ - click to readhow to upgrade ics on xolo x900 by usb data cable and from where to get the software of ics (4.0.4) and from which site because it is not downloading from ota
- 2013-09-20 21:55
- vQ%5
- arjun8074
frnds,do u hav any idea whyxolo sitedoesn't hav 4.0.4(ics) file(299mb)..and which updating phone with(299mb) is better or withOTA update is better? ...which wayof upgrading is better...plz contribute ur views frnds
- 2013-08-24 09:14
- bJe}
- arjun8074
battery backupafter4.0.4 ics updateof xolo x900..??.has.battery backupgone up or gone down ??.watsur review..
- 2013-08-24 09:13
- bJe}
- Pavi
> In reply to sreevats @ 2013-04-18 16:07 from t}fw - click to readSame issue with me also and showing 10 gb space in memory. Also facing the network signal issue........?
- 2013-08-06 20:05
- rxhq
- Sujoy
The phone itself is excellent. The ICS upgrade happened beautifully. But I have the same problem two others have had in this forum. The battery started acting quite erratic. With a full charge on, I couldn't even start making a call or open up a message. The handset just shut down. Also, it refuses to connect to the network.
The customer service is the worst. I live in Santa Cruz in the middle of Mumbai. There is NO AUTHORIZED SERVICE CENTER in Mumbai. I was first given a complaint number on the Xolo customer service line, and told that the handset would be collected by a Fedex operative. The phone was still in warranty.
Nothing happened for months and I kept calling and asking if the Fedex guy was ever coming. Three months went by. Then somebody at Xolo customer service helpfully told me that they would give me a new complaint number and the old one (which was registered during warranty) won't be acknowledged any more.
I have been given the address of a pick-up point in Malad, which is a grocery store. I have not been given a phone number. The address is sketchy, and I can't even call them for directions. If this is their state of affairs in Mumbai, I wonder what their service in other cities looks like.
I quite like the product, but the customer service is lower than the pits. I don't recommend anybody outside Delhi buy a Xolo product.
- 2013-08-05 15:41
- 2@sV
- niresh
frnzz...please dnt ever buy xolo x900...waste of money...the service care will not respond to the customer..i have send ma mob fr service before 2 months..yet nw i dnt recieve ma mobile..their simple reply is within 48 hours u will get ur hanset.....fuckd up
- 2013-07-09 07:02
- uuUp
- Sohan
hey world's worst mobile is this & customer care. i am suffering last 5 days. i had called to the customer care but they did not reply properly. if anyone want to buy this mobile please don't buy the XOLO product. its worthless. If anyone have money to waste than go head.
- 2013-06-22 12:22
- 2@60
Am giving the pros and cons of this phone with a neutral perspective as a 7-month old user of this phone.
1. Upgrade to ICS 4.0.4 OTA readiyl available
2. Excellent 1.7GHz processor with great speed of execution
3. No lags in games like Temple Run 2, subway surfers.
4. High end games like NFS or Asphalt run like a breeze. Only at very high graphic details, a slight lag is noticeable.
5. Out of the Box OS. No tweaks to the OS. This means lesser RAM usage for the OS itself.
6. Camera: Normal settings capture excellent photos with good color reproduction. Minimal manual settings available.
7. Connectivity: No complaints on what it promises to deliver.
8. Battery: A full day of charge when used for 20 mins of calling, 1 hour of music, 45 mins of browsing and continuous 3G connectivity(dual mode in network)
9. Display: Excellent natural colour reproduction with optimal saturation.
1. 3G browsing and games heat up the lower part of the mobile (where the chipset and antenna are located) to a relatively high extent.
2. No Jelly Bean Update
3. Lack of customizable settings in the camera for ISO, Whitebalance
- 2013-06-12 11:53
- t}CJ
- revanth
FOR GODS SAKE PLEASE DO NOT BUY INTEL XOLO MOBILES. I had brought a X 900 and only after 2 months it started giving me a network connection error. to add to this no service centre at chandigarh which is the capital city of 2 states.lodged my complaint with Xolo services told my mobile would be returned back in 5 working days and more than one month no response. service centre also doesnt get connected easily. keep on telling stories that within 2 days it will be despatched but no despatch really occurs.BLOODY fools they all will perish with my curses.
- 2013-06-11 19:12
- t@5a


text:
First Appearance
Latest Appearance
Effect on Player
"What do we have here...? Looks like a soft, white mushroom, eh? You know, the stuff you're finding is pretty weird... But I guess that's just the universe we live in, right?" —Lubba, Super Mario Galaxy 2
The Boo Mushroom is a type of Mushroom that appeared in Super Mario Galaxy and Super Mario Galaxy 2 and turns Mario into Boo Mario or Luigi into Boo Luigi. It's a white mushroom with a Boo-like face. When Mario or Luigi obtain this Mushroom, he will transform into Boo Mario or Boo Luigi. It is the least used power-up in Super Mario Galaxy, found only in the Ghostly Galaxy, Sand Spiral Galaxy, and the Boo's Boneyard Galaxy. It is used only once in Super Mario Galaxy 2, in the Boo Moon Galaxy.
The Boo Mushroom turns Mario into Boo Mario therefore giving him the power to do several things that ghosts do in the real world such as float through walls and fly. He can become intangible if the player shakes the Wii Remote and he can then go through the object. Another effect of being Boo Mario is that Mario will attract other Boos towards it and those Boos will make him lose the form by touching him. The only other way to become Mario from Boo Mario is to go into a light beam.
In the mission "Luigi and the Haunted Mansion", the Boo Mushroom appears for the very first time in the whole game at the end of the level when Mario has to actually free Luigi. It is in a room behind a moving light which will make exiting the room without losing the mushroom an extra challenge for Mario. Mario must then use the mushroom to travel along until he gets another mushroom which he must use to actually free his brother Luigi.
The Boo Mushroom reappears in the mission "Choosing a Favorite Snack" where Mario has the choice of either the Bee Mushroom or the Boo Mushroom. If Mario chooses the Boo Mushroom he will turn into Boo Mario and have to travel over a lot of quicksand. There is a boo at the start who will see Mario and fall in love with him, chasing him for several meters until it gives up. After that there are several lights all around trying to shine on him and make him lose his Boo Mushroom.
In the mission "Racing the Spooky Speedster", Mario makes his final encounter with the Boo Mushroom when he must use it to race the Spooky Speedster and to win the level. There are many shortcuts that can only be accessed by Boo Mario and no lights to make Mario lose his Boo Mushroom in the whole level making it one of the easier levels.
In the mission "Haunting the Howling Tower," Mario (or Luigi) must use the Boo Mushroom to go through walls and progress to the top of the tower.
When traveling through the Ghostly Galaxy, Mario needs some extra help to navigate this scary place filled with Boos and Bouldergeists. A Boo Mushroom is just what he needs. When Mario grabs this white mushroom, he transforms into Boo Mario and is able to float, and pass through solid walls for a short time.

subset: commoncrawl


text: Please Sign Up to Request This ProductTestable JavaScriptYou need to be an approved reviewer to request a product. Please sign up to request access or login to your account. If you've already signed up and you haven't heard from us yet please email firstname.lastname@example.com and we will check on your request. DescriptionOne skill that's essential for any professional JavaScript developer is the ability to write testable code. This book shows you what writing and maintaining testable JavaScript for the client- or server-side actually entails, whether you're creating a new application or rewriting legacy code. Top ReviewersMichal Konrad Owsiak, 82 Reviews Shawn Day, 55 Reviews Santosh Shanbhag, 51 Reviews Juan Jose de Leon, 49 Reviews Doron Katz, 48 Reviews Featured ReviewEder Andres Avila Nino wrote: Rating: |


text:
Preschool: Orange You Glad You Live in Florida? | |
Event Type: Children's Programs Date: 3/14/2013 Start Time: 11:00 AM End Time: 12:00 PM Description: I sure am! Preschoolers, join us for fun with all things orange as we learn about our sunny state with stories, crafts, and activities. Ages 3-5. #VivaFlorida
Library: North Orange BranchLocation: North Orange - Meeting Room Registration Ends: 3/14/2013 at 10:50 AM Presenter: Marilyn John Status: Closed |
We're sorry. The registration deadline was 3/14/2013 at 10:50 AM.


text:
Budget 2013: George Osborne must scrap the fuel duty rise
Families urgently need help with the cost of living. The Chancellor should take action on fuel duty and then examine a 10p tax rate.
by Robert Halfon Published
I am a moderniser. But I believe that the one area of modernisation that the Conservative Party should focus on is helping those on lower incomes, who are struggling to make a living. We need a Ronseal politics, which is easy to define. This is not about getting hung up about backgrounds, or what school you went to. In fact, most families would love to send their children to posh schools. But it's about being on the side of the poorest, even if we don't believe in the big state redistributionist welfarism of the Labour Party. David Cameron's declaration that "Conservatives are not the party of the better off, but the party for the want-to-be-better-off" should run through everything that we do - every speech, every Budget line, every policy decision. It must be our narrative, our metaphorical "washing line", holding all the clothes pegs together.


text:
Steve Hackett Mixing Live Release
Steve Hackett is currently mixing a live DVD for release shortly.
This is being mixed in 5.1 Surround sound, and was filmed last year at the Shepherd's Bush Empire in London.
"I was hoping to have it available to sell on my upcoming tour. But the way things are turning out, it won't now be finished in time. So I now expect it to be released next year. As yet, it doesn't have a title."
Hackett will be playing UK dates in November, with a fuller tour planned for February.
Find out more at www.hackettsongs.com
Tags: Steve Hackett


text:
thierry clement
Discovering a Restaurant: L'Ardoise
I've lived in the city since 1993 and since 1996, all of my editor jobs have required me to keep track of the restaurant scene. Generally, I have a smug sense of myself as someone that knows this scene pretty well.
Until I'm proven wrong. Which is pretty often for someone so smug.
Take the other night.
My husband and I recently moved to the cusp of Castro and Noe which has caused us to have to shed our usuals. Ten years in Bernal Heights made for usuals such as La Taqueria for tacos, Blue Plate for neighborhood restaurant needs, Argus for drinking and Emmy's Spaghetti Shack for kids' night out.
Essential SF knowledge in your inbox
The Big Eat 2010: 100 Things to Try Before You Die
Avoid the Line: Tartine's Morning Buns Recipe
Restaurants to Throw Parties At
Citywide Map of Third Wave Coffee Spots
The Best of the SF 2010: Our Picks for Food, Design, Fashion, Daylife and Nightlife
The Best 1-2 Punch Dates in the City


text:
GOLD RIPPLED GLASS AND CHROME 240V HALOGEN DECOR WALL LIGHT Retail price at leading lighting store - R345.00 Above: Stock image with reflector Uses 240V G9 bi-pin halogen (max 50watt) globe (included). Thick rippled glass body with chrome reflector. Rated for indoor use wall mount. 21.5cm x 21.5cm. Below: Actual images without reflector. Lights were used as display lights in a lighting store showroom and may have some very minor marks on the chrome reflector. This is very slight and not visible from a meter or two. Lights will come unboxed and globes are included. |
7 Days: Please see details in listing


text:
Writer/director/star James Franco dabbles in experimental filmmaking with this ambitious adaptation of William Faulkner's famed stream-of-consciousness novel. Told from the multiple perspectives of a poverty-stricken, rural Mississippi family determined to honor their late matriarch Addie's (Beth Grant) dying wish to be buried in Jefferson, the film follows the grieving clan on their arduous journey through difficult terrain. Headed by newly widowed father Anse (Tim Blake Nelson) the family includes a...more
50 out of 100 Metascore®
Mixed or average reviews
Read reviews
Iffy for 16+
All As I Lay Dying cast + crew photos


text:
Path to the 2012 Farm Bill: Senate Releases Draft Farm Bill
April 20th, 2012
This afternoon the Senate Agriculture Committe released its draft of the 2012 Farm Bill. In the summary of the draft that Chairwoman Stabenow (D-MI) released, she said that the bill achieves $23 billion in savings, which matches the Committee's proposal for the Super Committee last fall. The Committee is scheduled to mark-up the draft bill on Wednesday, April 25.
We are currently analyzing the bill for sustainable agriculture priorities and will be publishing a longer analysis soon – stay tuned!
For more information about where we are in the process and why this is a critical moment, read our previous post on the Senate farm bill process.
One Response to "Path to the 2012 Farm Bill: Senate Releases Draft Farm Bill"
1Legislative Update from Wes King at the Illinois Stewardship Alliance | Fed Up
April 24th, 2012 @ 4:33 pm[...] hearings over the past couple months, last week Chairwoman Senator Debbie Stabenow released a draft 2012 Farm Bill. The Senate Agriculture committee is set to debate and offer amendments to the legislation in a [...]


text:
Deloitte response to announcement on UK roads |
19 March 2012
Following today's announcement by the Prime Minister on the UK road network and infrastructure needs, Ian Simpson, Head of transport at Deloitte, the business advisory firm, said:
"Today's announcement is a valuable step forward towards the provision of adequate and stable funding for the country's strategic road network. New mechanisms such as tolling would provide a welcome addition to the funding landscape to deliver major transport infrastructure and economic growth.
"Across the UK road network, demand is forecast to continue to increase on all our major arteries and by 2025 congestion on the English road network will have risen by 27 per cent over 2003 levels.
"The feasibility study launched today will need to be comprehensive if it is to come up with a workable solution, balance attractiveness to the market with taxpayer value and win over a sceptical public.
"The study needs to examine the scope for the tolling of both new roads and additional lanes. A 2008 Government study into the charging of extra lanes on existing motorways found this is both technically and financially viable and could improve capacity in a shorter timescale.
"The government needs to consider how private operators can be incentivised to provide increased capacity. A user-based charge would do this but would require designing a complex mechanism to deliver it. Any new funding also needs to be targeted at the critical bottlenecks on our network, releasing schemes which are well developed and offer a high economic return.
"How new operators of the strategic road network would interact with the authorities who own and operate the remainder of the road network, Local Transport Bodies and Local Enterprise Partnerships also needs to be considered, particularly where the existing strategic road network links up to local authority roads."
About Deloitte
Deloitte LLP is the United Kingdom member firm of Deloitte Touche Tohmatsu Limited ("DTTL"), a UK private company limited by guarantee, whose member firms are legally separate and independent entities. Please see www.deloitte.co.uk/about for a detailed description of the legal structure of DTTL and its member firms.
The information contained in this press release is correct at the time of going to press.
Member of Deloitte Touche Tohmatsu Limited.
Last Updated:


text:
Yoga-Tree |
 Yoga Classes in Fairview Park Ohio |
Yoga-Tree Website | Contact:Jennifer McCutcheon Karabinus CYT | |
18801 Rivercliff Drive, Fairview Park, Ohio 44126 | Phone:216.534.7212 | |
Yoga Style: Iyengar Influenced | Send Message | |
Jennifer McCutcheon Karabinus has been teaching for over 18yrs. While based in Cleveland, Ohio, she travels teaching private lessons, workshops and volounteer community programs. Jennifer is currently involved is several yoga projects and therapeutic research studies. She is a Certified Yoga Instructor, a member of the International Association of Yoga Therapists and the Iyengar National Association of the United States (IYNAUS). | ||
Update listing |
You also might be interested in...
| Searching by USA Zipcode Ohio Yoga Retreats Ohio Yoga Workshops |


text:
US 4344431 A Abstract An article for dispensing drugs is disclosed which is formed from a crystalline polymeric material having a melting point of at least about 100 and the combination is formed into a solid shape having structural integrity.
Claims(8) 1. An article for controllably dispensing drugs, comprising:
a. crystalline polyethylene having a melting point of at least 100 C. formed into a solid shape which has structural integrity; and b. from about 0.5% to about 50% by weight based on said polyethylene of an addictive drug antagonist present in an antagonistically effective amount and substantially uniformly and intimately dispersed throughout portions of said shaped polyethylene with an outer surface of said solid shape comprising means for diffusing said drug antagonist therethrough with said drug antagonist exuding to said outer surface. 2. A controlled release drug dispenser comprising an intimate mixture of crystalline polyethylene having a melting point of at least about 100 antagonistically effective amount, said mixture being formed into a solid shape having structural integrity.
3. In the art of administering effective amounts of an addictive drug antagonist to a taker of an addictive drug which can be taken while the blood still contains the antagonist, the improvement which consists essentially of the steps of subcutaneously implanting in the body of an ambulatory, nonconfined drug addict a shaped article having structural integrity, said shaped article being formed from a crystalline polymeric material having a melting point of at least about 100 article having dispersed therein an effective amount of an addictive drug antagonist, thereby extending the ambulatory, nonconfined addict's period of cure beyond the time of actual clinical confinement.
4. An improvement of claim 3 wherein said polymeric material comprises polyethylene.
5. In the art of contraception by means of an intrauterine device, the improvement which consists essentially of the step of offering the added protection of an exuding contraceptive drug in effective amounts by inserting into the uterus of a woman an intrauterine device formed from a crystalline polymeric material having a melting point of at least about 100 dispersed therethrough an effective amount of a contraceptive drug.
6. An intrauterine device comprising:
a. a crystalline polymeric material formed into the shape of an intrauterine device; and, b. a contraceptive drug uniformly and intimately dispersed throughout said intrauterine device, said drug being present in an effective contraceptive amount. 7. An intrauterine device of claim 6 wherein said contraceptive drug comprises an estrogen or a progestin or a combination of an estrogen and a progestin.
8. An intrauterine device of claim 6 wherein said contraceptive drug comprises a spermicidal agent.
Description The polymeric materials used to manufacture the instant device must be crystalline and must have high melting points so that they won't soften when exposed to fairly high temperatures such as those encountered with human body fluids. Preferably the material will have a melting point of 100 temperatures. Some examples of suitable polymeric materials include, but are not limited to: polyamides such as nylons; polyolefins such as polypropylene and polyethylene; polyesters such as polyethylene terephthalate; vinyl polymers such as polyvinylidene chloride and polytetrafluoroethylene; polyacetals; cellulose acetate; polypeptides; polycarbonates; polyvinyl ethers and combinations of these. It has been found that polymers having a crystalline structure yield the most satisfactory control of drug release. Although the reason for this is not known, it may be because of the long segments of linear polymer chains regularly oriented with respect to one another in crystalline polymers. It is known of course, that crystallinity does have a marked effect on physical properties. See Flory, Paul J., Principles of Polymer Chemistry, 5th printing, 1966 at pages 49 et seq. It has also been reported in the literature that gaseous diffusion through polymeric membranes is slower, in general, for those polymers having higher degrees of crystallinity than for those with lower degrees of crystallinity. See Michaels, A. S. and Bixler, H. J., "Flow of Gases through Polyethylene and Rubbery Polymers" J. Poly. Sci., vol. 50, 413-39 (1961). While melting points can be a good indication of polymer crystallinity, the best evidence is obtained by x-ray diffraction patterns. Some preferred polymeric materials are polyethylene, polytetrafluoroethylene, and polyethylene terephthalate because they are commercially available, economical, and have the required physiological inertness required of any materials considered for implantation into the human body. Polyethylene is particularly preferred. The crystalline polymeric materials described above have drugs incorporated in them to form the article of this invention. The term drug is used in this description in its broadest sense and covers drugs useful to any mammals including, but not limited to, human beings, wild animals, household animals, and animals raised for their meat or other products such as farm animals and cattle. The term drug is further used in describing this invention to include, but not limited to, the following classes of drugs: (1) therapeutic drugs; (2) preventative drugs; and, (3) diagnostic drugs. It should be understood that a variety of classes, subclasses, and specific examples of drugs not expressly mentioned herein are within the scope of this invention, and these other drugs will be well known or easily ascertainable to those skilled in the art. Some specific examples of drugs which can be incorporated in crystalline polymers to form a device of this invention are described infra. As is well known, people suffering from sugar diabetes are required to take daily doses of diabetes control agents. Insulin or the active ingredients in some of the commercially available control agents such as tolbutamide ("Orinase" by Upjohn), chloropropamide ("Diabinese" by Pfizer) and tolazamide ("Tolinase by Upjohn) could be dispensed with an article of this invention. Many drugs are presently being used to treat rheumatoid arthritis and other forms of arthritis. These include, but are not limited to, narcotic pain relievers, gold salts, corticosteroids, adrenocorticotropic hormones, phenylbutazone and its derivatives, antimalarials, and indole derivatives. A comprehensive listing of specific drugs used to treat the various forms of arthritis is given in the Aug. 12, 1968 edition of Chemical and Engineering News at pages 54 and 55, which listing is herein incorporated by reference. These drugs could be dispensed with the instant article. Antibiotics are a further group of drugs which can be dispensed. Some examples of suitable antibiotics include the tetracyclines, penicillan, streptomycin, and aureomycin. Deworming and distemper drugs such as those given to household pets and/or cattle are another group of drugs capable of being dispensed by the device of this invention. An example of such a drug is phenothiazine. Sulfur drugs such as sulfisoxazole diolamine ("Gantrisin" by Roche Laboratory), useful in treating urinary tract infections, could also be exuded from a crystalline polymeric article. Another group of drugs suitable for use in the crystalline polymeric articles are the cancer-control agents. An example would be the drugs or combinations of drugs useful for treating leukemia such as the nitrogen mustard p-(di-2-chlorethyl) amino-phenylbutyric acid. Two further groups of drugs which could be advantageously dispensed with the hereindescribed device are alcohol-addiction control agents and tobacco-smoking addiction control agents. Closely related are the addictive drug antagonists. If an addictive drug such as heroin, morphine, codeine, neopine, etc. is taken while the blood still contains the antagonist, the addictive drug will pass through the body and be harmless to the taker in the sense that the taker will not experience "a high" and the drug will not be addictive. Such antagonists have offered a very successful method for treating drug addicts while the addicts are at clinics; however, it has been noted that once addict returns to his original environment, and is out of control of the clinic, he is likely to stop taking the antagonist and resume taking one of the addictive drugs. For this reason, the article of this invention offers unique advantages in treating drug addicts by this method since such an article containing an antagonist could be implanted within the addict's body, thereby giving him no control over the administering of the antagonist. This will extend the addict's period of cure beyond the time that he can actually be confined to a clinic. Some examples of specific drug antagonists suitable for incorporation into the polymeric dispenser include N-allyl-noroxymorphone ("Naloxone") and 2-cyclopropylmethyl-2'-hydroxy-5, 9-dimethyl-6,7-benzomorphone ("Cyclazocine"). Other drug control agents such as "Methadone" can also be used. Two further groups of closely related drugs are the thyroid gland regulating drugs and weight-control drugs. Here again, there is a particular advantage to the use of the polymeric dispenser since such a device can be implanted within the body of the patient and thereby supply the required amount of drug without the patient having any control over this. Also, it is known that these types of drugs are extremely dangerous when taken in large doses, and the use of this device would help assure that an overdose did not get into the patient's bloodstream. Another group of drugs which could be dispensed are the analgesic drugs. These drugs have little or no therapeutic effect, but serve to lessen or eliminate the severe pain often encountered with many diseases or operations. For example, in the cases of chest cancer, morphine or codeine are often prescribed. Also, for patients suffering from cancer of the prostate glands, progesterone is often prescribed. One particularly advantageous use of the polymeric dispenser would be in serious surgical operations which result in severe pain to the patient after the operation is completed and the patient regains consciousness. In these cases, the body is going to be opened for the operation, and a device of this invention containing a pain killer could be inserted into the body during the operation to ease the pain to the patient during the recovery period. Of course, there are many other types of analgesic drugs and many other examples of when such drugs could be used which will be apparent to those knowledgeable in the field of medicine. Another group of drugs suitable for being dispensed from the polymeric article are the hormone-regulating drugs to aid fertilization or to act as contraceptives. One preferred embodiment using hormone-regulating drugs is formed using the active ingredients in oral contraceptives. The advantage is that a device containing the active ingredients of oral contraceptives could be designed to last over extended periods of time thereby relieving the taker from a daily routine of orally taking the contraceptives. Suitable examples of the active ingredients in oral contraceptives include a progestin or a combination of a progestin and an estrogen. For example, a homogeneous dispersion of the active ingredient in "Norethindrone" and "Mestranol" in a ratio of 20:1 by weight could be prepared and incorporated into the solid polymeric material. Other examples of synthetic progesterones and estrogens suitable for use with this invention include: Norethynodrel, Medroxyprogesterone acetate, Dimethisterone, Ethynodiol diacetate, Chlormadinone acetate, Norethindrone acetate and Ethynylestradiol. One particular advantageous embodiment is the combination of an intrauterine device and the article of this invention. This can be prepared by forming a suitable polymeric material containing an oral contraceptive into the shape of an intrauterine device. The device could then be inserted into the uterus of a woman and would offer the double protection of the exuding oral contraceptive and the intrauterine device principle. The intrauterine device could have any shape including, but not limited to, a spiral, bow, loop, ring, coil, or trefoil. Besides using contraceptive combinations of steroids in such a device, it would also be possible to use a spermicidal agent such as the terpenylphenyl polyoxyethylene ethers described in Furuse, U.S. Pat. No. 3,514,517. Other drugs which can be incorporated in the systems of this invention include: drugs for reducing blood pressure such as those described in U.S. Pat. No. 3,469,005; pharmaceutical compositions for the control of appetite such as the combinations of amphetamines and thioridazines described in U.S. Pat. No. 3,495,005; and, agents for treating psychosis in mammals such as those described in U.S. Pat. No. 3,495,007. The above listing of drugs is not intended to be comprehensive, but merely representative of the wide variety of drugs which can be used with this invention. Those skilled in the art will know or be able to determine by routine experimentation that many other specific drugs are also suitable. The amount of drug dispersed in the polymeric article will depend, of course, on many factors including the specific drug, the function to be accomplished, the length of time it is desired to dispense the drug, the amount of drug to be dispensed in a specified time, the size of the device, and many other factors. In general, amounts ranging from about 0.5% to about 50% by weight of the polymeric material can be incorporated. Particularly good results can be obtained with from at least about 10% to about 20%, The amount of drug to be dispensed in a specified time, will of course, depend on such factors as the particular application, the particular drug, the age of the patient, etc. In general, what will constitute an "effective amount" will be known or easily ascertainable by those skilled in the art. Much of this type of data is published in the literature or easily determined by routine experimentation. Examples of the published literature on effective amounts of progestin-type steroids, in this case for topical application, can be found at: Shipley, "Effectiveness of Topical Application of a Number of Progestins", Steroids 5(5): 699-717, May, 1965; and Ringler, "Efficacy of Topically Applied Progestational Agents", Steroids 7 (4): 341-349, April, 1966. In a like manner, the following literature describes effective amounts of addictive drug antagonists: Martin, W. R., "Opioid Antagonists", Pharmacological Reviews, vol. 19, no. 4, pages 463-521 (1967) and references contained therein; Freedman, A. M., "Cyclazocine and Methadone in Narcotic Addiction", The Journal of the American Medical Association, Oct. 16, 1967, vol. 202, pages 191-194. Also, the patents mentioned above often contain data on effective amounts for any particular application. The dosage administered by this dispenser can be controlled by the size and shape of the article, concentration of the drug in the polymer, surface area, pore size, matching of the polymer and drug, nature of the surroundings, etc. This is a particular advantage where it is desirable to deliver a metered amount of the drug over a specified period of time. Of course, combinations of drugs and substances in addition to drugs can also be incorporated into the polymeric material. For example, radioactive tracers such as carbon-14, nonradioactive tracers such as barium sulfate, carriers which would transport the drug through skin such as dimethylsulfoxide and dimethylsulfone, water-soluble excipients, etc. could be incorporated with certain drugs for particular applications. The amount of auxiliary agent used will depend, of course, on the specific agent, drug and polymer used to fabricate the article as well as the purpose for incorporating the auxiliary agent. As has been described, the polymeric article dispenses the drug it contains by exuding it to the surface of the article. The mechanism of how the drug enters the body from the polymer surface is not critical and can be accomplished with a variety of techniques. For example, the article may be placed upon a person's body in contact with the skin so that the particular drug could be absorbed through the person's skin into the bloodstream. An alternative technique is to implant the device within the patient's body at a location where the surface layer of drug will be in contact with any of the various body fluids or tissue so that the drug could be dissolved and/or carried away by such body fluids or rubbed off and absorbed by the tissue. Subcutaneous implantation of a film drug dispenser under the skin on the back of a rat is shown in FIG. III; a more detailed description of such implantation techniques is presented in the examples. Intramuscular implantation is also contemplated. Still another technique would be to prepare the article for use in the patient's mouth so that the saliva would carry the drug into the body. In certain cases, it might be advantageous to insert the dispenser in other body cavities such as the uterus. Other techniques for getting the material from the surface of the article into the body will be readily apparent to the medical profession. The dispensing articles described herein can be formed by pre-mixing the polymer, drug and any auxiliary agents to be incorporated with the drug and then following conventional techniques to shape and set the article. For example, the polymer and drug can be mixed together in a suitable solvent until a homogeneous solution is formed. After driving off solvent, the residue can be molded, extruded, etc. to the desired shape. Another method of forming the dispenser might be to compact at elevated pressures a dry mixture of drug and polymer. Also, monomer and drug can be mixed with subsequent polymerization of the monomer. Another method of forming the drug dispensers is to soak a previously shaped piece of polymeric material in a solution of the drug to be incorporated, and subsequently drying the surface of the article. This technique must be distinguished, however, from simply dipping a polymeric article in a solution to coat the surface of the article with a substance. In the soaking technique of this invention, the conditions, i.e. solvent, polymer, temperature, etc., must be carefully chosen to insure that the active ingredient penetrates deeply into the polymer matrix instead of remaining only on the surface or penetrating a small distance below the surface as a coating does. One way to accomplish the desired deep penetration is to choose a solvent which causes the polymer to swell in the solution of drug. Some solvents cause swelling at room temperatures; others require elevated temperatures. Once the polymer has swollen, solvent and active ingredient can penetrate deeply into the polymer matrix. With rapid cooling, the polymer returns its non-swollen condition trapping solvent and active ingredient within it. If the solvent chosen is highly volatile, while the active ingredient is not, the solvent can be driven out of the article by continuous pumping, i.e. exposing the article to reduced pressures. Those skilled in the art will be able to select appropriate conditions for carrying out this technique. Other methods for making the polymeric dispensing articles will be apparent to those skilled in the art. An important feature of the dispenser, which results from the way it is prepared, is that there is a substantially intimate dispersion of drug throughout polymer. This is to be contrasted with a foraminous plastic matrix containing discrete solid particles of a drug only within the voids, such as described in U.S. Pat. Nos. 2,987,445 and 3,087,860. In these patented systems, drug release is predicated upon water or other liquids leaching the drug from the voids; in the dispenser of this invention, drug release is predicated upon exudation of the drug to the polymer surface. Another important feature of the dispenser, which also results from the way it is prepared, is that the dispenser has "structural integrity". This means that the shaped dispenser will remain intact after prolonged exposure to body fluids. Although it is difficult to list all of the factors which contribute to the structural integrity, some include: substantial non-solubility and non-swellability in water or body fluids; relatively high tensile strengths; and good elongation at break and tensile modulus. Additionally, the polymeric matrices of this invention do not soften appreciably at temperatures as high as 100 of the prior art waxy binders do. A test to establish structural integrity is as follows. The shaped drug carrier is immersed in distilled water at 37 this period, weight loss of carrier and dimensional changes of carrier should be less than 10% of their original values. The polymeric matrices of this invention meet this test. The shape of the dispenser will depend on its intended use. Any shape is within the scope of this invention. Some possible and preferred shapes are illustrated in FIG. II wherein (a) illustrates a film, (b) illustrates a contraceptive intrauterine device known as the Lippes Loop, (c) illustrates a piece of hollow tubing suitable for implantation or for use as a catheter, and (d) illustrates various sized solid spheroids which could be injected into a patient or orally ingested by the patient. Other shapes contemplated but not shown include solid "sphagetti-like" and "fiber-like" configurations and a mesh configuration which would be expected to minimize the possibility of a device subcutaneously implanted causing blood clotting. The drug dispenser can also be shaped as a body organ or any part thereof. For example, an artificial heart valve could be formed from a polymer containing a drug which would lessen rejection of the new valve. Those skilled in the art will know many other organ shapes to which the drug dispenser could be formed. As is evident from the forgoing discussion, the article of this invention has many uses, all of which fall within the general utility of dispensing drugs to mammals. The following examples serve to further illustrate the invention. All parts and percentages are by weight, unless otherwise specified. Eighty parts of polyethylene resin as fine powder is dissolved in 320 parts of boiling toluene. Twenty parts of a mixture of norethindrone (19.048 parts) and mestranol (0.952 parts) is added slowly with stirring to the refluxing polyethylene-toluene solution. When the solution has cleared indicating homogeneity, the volatile solvent toluene is removed by flash distillation at reduced pressure. The residue consists of an intimate dispersion of norethindrone-mestranol in polyethylene. The hot, semi-solid mass is formed into solid shapes having the geometry of any of the well-known intrauterine devices by conventional polyethylene molding techniques. Each is suitable for intrauterine insertion into the uterus of a woman to dispense effective amounts of the norethindrone-mestranol contraceptive combination. Analysis of a device reveals that the composition consists substantially of 80 parts polyethylene and 20 parts of a mixture of norethindrone and mestranol. To demonstrate that a contraceptive combination of drugs could be released, polyethylene implants prepared as described above except shaped as films instead of IUD's were subcutaneously implanted into the backs of rabbits. Trace amounts of radioactive tagged ingredients were used with the norethindrone-mestranol combination. Measurements of the disintegrations per minute with scintillation counting equipment of samples of rabbit blood and urine demonstrated that effective amounts of the contraceptive combination were being released from the device to the rabbits bloodstream. Eighty parts of polyethylene resin as 1/8 inch cubes and 20 parts of N-allyl-noroxymorphone are blended on a steam heated two-roll rubber mill. This mixture is then placed in a conventional twin screw extruder and extruded into flexible tubing of 1/16 inch diameter. This tubing can be subcutaneously implanted into various parts of a drug addict's body, and when so implanted will release the N-allyl-noroxymorphone to the addict's bloodstream. Alternatively, the tubing could be extruded as a hollow catheter and implanted by catheterization techniques. Eight grams of powdered polyethylene resin and two grams of progesterone together with a trace of radioactive tagged progesterone are dissolved in 250 milliliters of hot xylene. The clear solution is evaporated down to about one-half of its original volume and the remainder is poured onto glass plates where the solvent is allowed to evaporate. The remaining solid mixture is placed in an oven at 100 drive off remaining solvent. Films are formed by placing the dried solids between two sheets of aluminum foil and pressing at 150 Carver press. The films are formed with a circular shape having a diameter of 3-4 inches and a thickness of 5 to 6 mils. If desired, the pressing technique is repeated to make the films more uniform. A polyethylene film prepared as described above was cut into one-inch squares. Four of these one-inch squares were subcutaneously implanted into the backs of four rabbits. Each film section weighed approximately 250 milligrams and contained about 50 milligrams of progesterone. After implantation, the rabbits were placed into metabolism cages. Release of progesterone into the blood stream of the rabbits was monitored by radioactive counting of blood samples taken periodically from the hearts and 24-hour urine samples. The release of progesterone for one rabbit is shown in FIG. I plotted as milligrams of active ingredient delivered per day. Table I presents the initial and final rabbit weights for the period of testing, the implant weights, and the radioactive count of blood samples 48 hours after implantation. As can be seen from the radioactive count of blood samples, the progesterone was being released by the implant to the rabbit's bloodstream. Table II presents progesterone release data obtained from the urine samples collected. As can be seen, each of the rabbits was receiving daily dosages of progesterone from the implant over the period of testing. After the test period, each of the four rabbits was killed by intracardiac injection of 1,1,1-trifluoro-2-bromo-2-chloroethane. The implants were recovered by dorsal incision, inspected and placed as found into paper envelopes. There was very little visible tissue reaction Small amounts of clear fluid were found in the "tissue" pouch around the implant. The removed implants were weighed and subsequently dissolved in xylene so that a final radioactive count and weight loss after 60 days could be checked. The results are shown in Table III. TABLE I______________________________________ DPM*/ml. of blood Final Rabbit Initial Rabbit Implant after Weight AfterRabbit Weight, kg. Weight, gm. 48 hours. 43 days, kg.______________________________________A 2.14 0.2488 8 3.5B 2.18 0.2500 5 3.4C 1.84 0.2592 34 3.2D 1.94 0.2103 14 3.1______________________________________ *disintegrations per minute TABLE II__________________________________________________________________________URINE COUNTS, ACCUMULATED DPMPERIOD: 24 hr. 48 hr. 96 hr. 7th day 11th day 14th day 25th day 29th day 39th day__________________________________________________________________________Rabbit: A 172,393 376,199 680,383 961,818 1,101,648 1,177,648 1,373,998 1,473,468 1,624,768B 198,700 475,055 820,913 1,136,913 1,495,473 1,665,123 2,089,688 2,218,680 2,507,576C 174,948 471,468 839,004 1,095,092 1,356,887 1,479,131 1,691,631 1,742,931 1,825,321D 118,779 356,046 657,966 924,973 1,136,023 1,283,723 1,530,788 1,673,977 1,809,127.__________________________________________________________________________% Delivered Calculated from Radioactive Count after 39 DaysA--47.5%B--73.5%C--53.5%D--53.0%__________________________________________________________________________ TABLE III______________________________________ % Active Ingredient Delivered Residual By Residual Count By Weight Count Final Implant After 60 Method MethodRabbit Weight, gm. days, DPM 60 days 60 days______________________________________A 0.2056 452,000 86.8 86.7B 0.2059 527,000 88.2 84.5C 0.2130 835,000 89.1 76.4D 0.1730 458,000 88.7 84______________________________________ A subcutaneous implant in the form of polyethylene film is prepared as in Example III except that 20% cyclazocine with a trace of radioactive tagged cyclazocine is used as the active drug. Cyclazocine is an addictive drug antagonist. Pieces of a film prepared as above were cut into two centimeter square areas. Some pieces were weighed, combusted and radioassayed to provide a measure of the concentration of radioactivity present in each piece. Other pieces of the same film were implanted subcutaneously in the backs of rats under light ether anesthesia. The stab wounds were sutured and remained so until the end of the experiment at which time the wounds were reopened and remaining implants were removed for final radioassay. The rats were placed in Acme metabolism cages for 62 days for the spearation and collection of urine and samples. Total daily urinary radioactivity was measured daily for the first ten days and every four days thereafter. This was accomplished by liquid scintillation techniques and the data was reported as "% of dose excreted per day" and also as "cumulative % of dose". The final radioassay indicated that all of the cyclazocine was released from each device in each rat. The results are presented in Table IV. TABLE IV__________________________________________________________________________% CYCLAZOCINE RELEASED, CUMULATIVEDay 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20__________________________________________________________________________Rat A 11.0 15.1 19.6 21.5 25.7 27.7 30.2 48.4 50.2 51.6 52.7 53.8 54.9 56 56.4 56.8 47.2 57.6 58.6 59.6B 7.6 11.6 13.6 15.5 17.4 18.7 19.3 21.0 24.3 26.5 27.2 27.9 28.6 29.3 30.1 30.9 31.7 32.5 33.6 34.7C 11.5 16.7 19.3 20.0 21.5 23.7 24.8 25.9 27.0 28.5 30.0 31.5 33.0 34.5 35.6 36.7 37.8 38.9 40.0 41.1.__________________________________________________________________________RAT AND IMPLANT DATA Initial Initial Rat Implant Initial Weight, gm. Weight, gm. DPM__________________________________________________________________________ Rat A 675 0.1312 268,960 B 590 0.1377 282,285 C 680 0.1304 267,000.__________________________________________________________________________ Six grams of polylactide with a molecular weight of about 40,000 prepared from L(-) lactide according to Example I of British Patent Specification No. 1,040,168 is dissolved in 250 milliliters of chloroform. Three grams of tributylcitrate and 2.25 grams of cyclazocine are added to the hot stirred solution. This is followed by the addition of five milliliters of a trace of radioactive cyclazocine to monitor drug release. The solution is evaporated to about one-half its original volume and poured onto glass plates. The residue on the plate is air-dried for 20 minutes and oven-baked at 100 pressing the dried material between sheets of aluminum foil on a Carver press at 140 p.s.i. Samples of films prepared in this manner were implanted into the backs of rats and cyclazocine release was monitored by radioassay. Implant and radioassay techniques were the same as those described in Example IV. The results are presented in Table V. TABLE V__________________________________________________________________________% CYCLAZOCINE RELEASED, CUMULATIVEFilm Pressed at 140Day: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20__________________________________________________________________________Rat: D 6.9 11.9 14.9 16.1 17.0 18.0 18.7 19.4 20.0 20.7 21.0 21.3 21.6 21.9 22.2 22.5 22.8 23.1 23.4 23.7E 4.4 7.7 9.2 10.5 11.6 12.3 13.5 14.3 15.4 16.7 17.3 17.9 18.5 19.1 19.3 19.5 19.7 19.9 20.1 20.3F 0.8 4.1 6.1 7.5 9.3 10.5 11.3 12.3 13.3 14.1 14.6 15.1 15.6 16.1 16.6 17.1 17.6 18.1 18.3 18.5__________________________________________________________________________Film Pressed at 135 Day: 1 2 3 4 5 6 7 8 9 10__________________________________________________________________________Rat: G 38.0 63.6 76.9 78.4 80.8 81.5 81.8 82.2 82.4 82.5H 17.0 32.0 39.3 45.1 50.0 53.6 56.8 60.2 63.4 65.9I 14.0 24.3 25.3 28.2 32.1 34.6 37.7 40.1 41.5 42.5__________________________________________________________________________Film Pressed at 130Day: 1 2 3 4 5 6 7 8 9 10__________________________________________________________________________Rat: J 30.7 62.4 81.9 89.0 89.5 89.8 90.0 90.2 90.5 91.7K 15.2 37.0 58.6 75.5 83.8 84.6 84.8 84.9 85.1 85.8__________________________________________________________________________RAT AND IMPLANT DATA Initial Initial Implant Initial Weight gm. Weight, gm. DPM__________________________________________________________________________ Rat D 645 0.0671 1,970,000 E 520 0.0708 2,080,000 F 350 0.0732 2,150,000 G 690 0.0512 1,475,000 H 670 0.0548 1,580,000 I 530 0.0690 1,990,000 J 520 0.0791 2,070,000 K 580 0.0942 2,450,000__________________________________________________________________________ FIG. I is a graphical representation of the controlled release of the steroid progesterone from a device of this invention to the bloodstream of a rabbit; FIGS. II(a)-(d) are perspective views of some of the variety of shapes of controlled release drug dispensers of this invention; FIG. III is a perspective view showing the subcutaneous implantation of a controlled release film device of this invention into the back of a rat. 1. Field of the Invention This invention relates broadly to the controlled release of drugs to the bloodstream of mammals and more particularly to a shaped article formed from a crystalline polymer which contains a drug so that the article is suitable for implantation in a mammal to controllably release the drug. 2. Description of the Prior Art Medical science has long recognized the need for methods to controllably release therapeutic agents and other drugs to the blood stream fo patients. Recently, a great deal of research has been initiated in attempting to find new release systems to fulfill this need. Several such systems have been recommended. One common method for obtaining controlled release is to envelop the active substance with coatings which are attacked by digestive juices in the stomach. This technique has been widely used recently for time-release analgesics. There are some problems with this method, however, such as: (1) it is difficult to obtain the proper distribution of coating thicknesses to give the desired release; and (2) the sojourn time of the coated agent in the digestive track is relatively short, thereby making this method unsuitable for long-term release. Another method of obtaining controlled release is to mix the active substance with various binders such as fats, waxes, and natural or synthetic polymers to slow down release. Many of the binders, however, are unsuitable for use with many drugs. Furthermore, these combinations of binders and drugs tend to disperse quickly after they enter the body due to the binder's solubility in body fluids, the washing effect of the body fluids and/or the attack of digestive juices. After the binder has been so dispersed, all control over the release of the drug is lost. Other researchers have even suggested that drugs be chemically modified to affect their release and absorption into the bloodstream. The degree of difficulty to this method for obtaining controlled release is clear. More recently, the possibility of somehow incorporating drugs into polymeric materials to control drug release has been considered. Thus Furuse et al., U.S. Pat. No. 3,514,517, teach that suppositories containing spermicidal agents can be formed by blending the agents with low molecular weight polyethylene glycols; Hill, U.S. Pat. No. 3,458,622, teaches that tablets for controlling the release of medicinal agents for up to eight hours can be formed from a blend of a polymeric vinyl pyrrolidone with a carboxy vinyl hydrophilic polymer; Weil et al., U.S. Pat. No. 3,469,005, teach that drugs for reducing blood pressure in mammals can be incorporated into solid vehicles such as lactose, cornstarch, microcrystalline cellulose, talc, stearic acid, magnesium stearate, gums, etc.; Merabi et al., U.S. Patent 3,495,000, have found that controlled release matrices can be prepared consisting of a dialdehyde starch and ethyl cellulose, polyvinyl chloride or polyvinylpyrrolidone, but that mixtures of the same starches with other pharmaceutically acceptable polymers such as methylcellulose or carboxymethylcellulose do not yield compositions suitable for controlled release; and Herrmann, U.S. Pat. No. 2,155,658, teaches that medical preparations for injection into the body which are flowable above body temperature but solid at body temperature after injection can be made from polymerized vinyl alcohols and their water soluble derivatives and a solvent for such material. Another technique for incorporating drugs into polymeric matrices is described in Levesque, U.S. Pat. No. 2,987,445 and in Endicott, U.S. Pat. No. 3,087,860. These patents teach a drug dispenser formed from synthetic polymers containing solid particles of a water-leachable drug. Usually the polymer matrix is shaped in the form of a pill which is intended to be orally ingested. This drug dispenser is limited, however, to water-soluble drugs and has relatively short release times, i.e., typically 8-12 hours. While the above-mentioned patents describe various mixtures of drugs with polymers, Long et al. have taught another method for constructing a controlled release device from polymers in U.S. Pat. No. 3,279,996. Long et al. form a capsule or container from polysiloxane which is intended for implantation. This device has the advantage of making extended time-release treatment possible, but suffers a disadvantage since the possibility exists that the polysiloxane container will develop pinholes or a rupture resulting in an undesired and potentially harmful large amount of drug being released almost instantaneously. In spite of all of the work being carried on to find suitable polymeric vehicles for dispensing drugs controllably, to date the incorporation of drugs throughout crystalline polymers shaped to various solid forms which have structural integrity after implantation has not been considered. It has now been unexpectedly found that an intimate mixture of a drug and a crystalline polymeric material can be formed to a solid, shaped article which will unexpectedly exude the drug to the surface of the polymeric article. For purposes of this description, the term exude is used to mean the migration from the interior of the polymeric material to its surface until the surface is covered with a layer of the drug and an equilibrium is established between the surface layer and the drug at the interior of the polymeric material. If the surface layer is partially or totally removed, the equilibrium is destroyed and further amounts of the drug permeate to the surface until equilibrium is re-established. This cycle will repeat itself until the supply of drug has been exhausted from the polymeric material. The surface layer can be removed in many ways, including but not limited to: rubbing it off; brushing it off; washing it off; dissolving it off; etc. Relying upon this discovery, a novel article for dispensing drugs has been invented which comprises: 1. a crystalline polymeric material having a high melting point and being formed to a solid shape having structural integrity; and, 2. a drug substantially uniformly and intimately dispersed throughout portions of the polymeric material. There are many advantages to this drug dispensing device over those previously known. For example, this device provides an economical and reliable method for automatically dispensing controlled quantities of a drug over a short or an extended period of time. Such a device can be implanted within a mammal's body so that it will dispense the required amounts of one or more drugs continuously over extended periods of time without the patient having to rely on periodic injections or oral ingestion of drugs. Once implanted, the dispenser can be forgotten and the patient can rest assured that his body is continuously and automatically receiving the prescribed amount of drug. A particularly unique advantage of this device is found in the types of therapy where it is desirable to insure that a patient receives a certain amount of a drug, and it is desirable to place control of administering the drug beyond the patient. This obviates the possibility that the patient will forget to administer the drug. It also prevents the patient from deliberately not administering the drug on his own volition, which has heretofore been a serious problem in many types of medical treatment. Once implanted, the drug dispensing devices of this invention are effectively out of the control of the patient. A most important advantage of the polymeric drug dispenser described herein is the degree of flexibility which can be obtained in administration techniques. As stated above, one suitable method for releasing the drug from this device to a mammals bloodstream is to subcutaneously implant the device. There are many other methods, however. For example, the device can be extruded into the shape of thin "spaghetti" which can be injected into the bloodstream, or the polymeric material can be formed into various sized spheroids for ingestion or injection by a patient. Additionally, the polymeric material can be formed into hollow tubing suitable for catheters. In short, the dispenser of this invention can be formed into limitless solid shapes each suitable for particular methods of controllably releasing a drug to the patient's bloodstream. This application is a continuation of application Ser. No. 798,535, filed Dec. 12, 1974 now abandoned which, in turn, is a division of Ser. No. 102,432, filed Dec. 29, 1970, now U.S. Pat. No. 3,880,991 and which, in turn, is a continuation-in-part of application Ser. No. 809,946, filed Mar. 24, 1969, and now abandoned. Patent Citations
Referenced by
Legal Events
Rotate |


text:
Robin van Persie scored against his former side Arsenal once again as Manchester United won 1-0 at Old Trafford. Elsewhere, Sunderland extended Manchester City's poor away run with a 1-0 victory of their own.
Europe's top flights battled on amid the snow and freezing temperatures over the weekend, with a memorable Manchester United comeback among the highlights.
After taking over Sunderland a month ago with the side in the doldrums, Martin O'Neill looks to have rediscovered the magic touch he showed at Leicester City and Celtic by turning the club into a resilient force.
Manchester City cruised to a 3-0 victory at home to Stoke City to ensure first place in the Premier League at Christmas, while chasers Manchester United and Arsenal both secured precious away victories.
Sir Alex Ferguson has moved to protect his young players, insisting they will not be "hounded out" of the club despite their exit from the UEFA Champions League in midweek.
The defensive shortcomings of Estonia's Ajax Lasnamae, the goalscoring prowess of Demba Ba, Fernando Cavenaghi and Cristiano Ronaldo, plus a goal drought in Cesena, are the focus of FIFA.com's latest stats review.


text:
Titans vs. Steelers: Breaking Down Pittsburgh's Game Plan
By Curt Popejoy ,
Well, football fans, it is finally here. The six-month void that we all must endure is over. The NFL has returned, and with it all the excitement and ceremony of the greatest sport in the world is back.
This week the Pittsburgh Steelers host the Tennessee Titans with both teams looking to find a way to earn not only a spot in the playoffs, but the respect of their peers.
Neither the Steelers nor the Titans seem to be getting much in the way of positive press from the national media. Much of the Steelers lack of hype is due to the relative depth of the AFC North. The Steelers could be a very good team and still finish third this year against teams like the Baltimore Ravens and the Cincinnati Bengals.
But those teams don't matter this week. What matters is the Titans are coming to town and bringing with them one of the most electric running backs in the NFL in Chris Johnson. The Titans also bring a punishing, physical defense and re-tooled offensive line.
Let's take a close look at what the Steelers must do this week if they want to beat the Titans.
Winning on first down will be vital. This is a team that for all the discussion about the passing offense is going to run the football.
But becoming predictable in their run selection has hurt this team in the past. The Titans defense is big and strong and will be ready to plug those lanes.
If the Steelers want to win on first down, they need to do so by extending the run game with properly used pass plays. There cannot be tremendous confidence in Isaac Redman as a primary back, so why not use the team's top weapons on the most important down?
Early in drives, the Steelers must use 11 personnel (one running back, one tight end), and get as many of those athletic receivers on the field as possible. Antonio Brown, Emmanuel Sanders and either Markus Wheaton or Jerricho Cotchery on the field early puts the Titans defense on their heels.
The Steelers do a great job on first down play action, pulling the linebackers up and dragging a wide receiver in behind them. If the Titans don't bite, the back ends up in the shallow flat or the tight end runs a stop. Either way, the Steelers have options to get six or seven yards on first down, leaving much more manageable down and distance on second down.
If the Steelers are able to win on first down, they can open the playbook up on second down. This is where the Steelers can run a jet sweep out the shotgun or test the Titans corners deep on that deep post from the slot receiver.
One thing the Steelers cannot do is revert back to the old, run on first down, run on second down, throw on third down mentality. This will lead to the punter getting the game ball.
The key will be stopping running back Chris Johnson on first down. You can bet that the Titans are going to come out and try to get big chunks of yards on first down, giving Jake Locker a much more manageable second down.
Attacking the line of scrimmage will be key. The Titans have gone to great lengths to upgrade the talent on the offensive line, but there are still spots the Steelers should be able to exploit. The front line of Brett Keisel, Steve McLendon, and Ziggy Hood have played with excellent leverage this preseason. This has allowed Lawrence Timmons and Troy Polamalu to fly to the football on run plays.
I cannot stress enough that the Steelers have to be aggressive in their defensive game plan. Playing off coverage and not choosing to blitz is going to make an average quarterback look great.
Locker is susceptible to pressure in his face, and that should play right to the strength of the Steelers defense. On passing downs, in the nickel I would send Timmons up the middle, or LaMarr Woodley on a twist every chance I got. Force him to make his hot read and try and check the football down.
Another key is how the Steelers handle the play-action pass when Locker rolls out. For all his faults, Locker is still a very athletic quarterback and is dangerous when he rolls to the edge and has a run/pass option. The Steelers will have to be disciplined on defense because if he can pull the defenders to the line of scrimmage expecting him to run, he can beat them over the top.
But ultimately, the plan is simple: Force Locker to beat them with his arm, from the pocket. Picking their spots to bring pressure, well-timed run blitzes and sound fundamentals on the back end is how the Steelers defense keeps the Titans out of the end zone.
Veteran running back Isaac Redman has been anointed as the starting running back this week, but I continue to maintain that LaRod Stephens-Howling is a better fit for what the Steelers want to do with the run game.
His ability to make one cut and get up field is tops among the Steelers running backs. Failing to do this was a big reason Jonathan Dwyer is no longer on the roster.
Watching this team in preseason it was clear that the days of the slow-developing run plays are over. The offensive line hasn't shown that they can maintain that power blocking scheme fans have grown accustomed to.
This blocking scheme and offensive line talent means making quick decisions when those small creases appear. This is a strength of Stephens-Howling, and I expect a few big runs from him on Sunday; particularly on that off-tackle play off the right side.
The role of Ryan Clark could be focused primarily as a deep coverage player on Sunday. The threat of the run is going to keep fellow safety Troy Polamalu up around the line of scrimmage for much of the game.
This means Clark is going to have to put on his enforcer hat and help out the Steelers cornerbacks.
Clark isn't an elite player in coverage, but he is a hammer. Titans wide receivers Kenny Britt and Nate Washington need to understand early if they make a catch, they are going to pay the price.
Creating even a moment of hesitation in the wide outs will go a long way toward a plan geared around stopping the run. Fortunately, what Clark averages in overall athletic ability he more than makes up for in intelligence and understanding of the scheme.
Titans cornerback Coty Sensabaugh is going to have his work cut out for him. Whether it's the veteran Jerricho Cotchery or the speedy rookie Markus Wheaton, this could be the matchup that the Steelers choose to exploit.
The Steelers love to use their slot receiver by putting them in motion to show coverage. If Sensabaugh is in man coverage on Wheaton, that shallow cross is going to be very hard to defend. It appeared in preseason the Titans ran a great deal of man coverage, so which the Steelers don't do a lot of shifts, they do like to pull their slot receiver across the formation.
This means Sensabaugh could be chasing even before the ball is snapped. Now that I think about it, the matchup between dime cornerback Tommie Campbell is going to have to be on point as well because he is going to draw either Cotchery or Wheaton as well.
Campbell lost his job as nickel corner in camp, and he and Sensabaugh could each have a bull's-eye on their chest as a potential advantage that Ben Roethlisberger can exploit.


text:
It is frustrating. I have 2 sites that are a bit "younger" than 8 years - 6 and 7 years old respectively. Never engaged in blackhat / greyhat / whatever for either site. Both got hit by Penguin 1.0 when they were 5 and 6 years old respectively. Never recovered to this day - in fact, they just slipped away a few spots at a time, from all the "fly in the ointment" links they win. They get loads of spammy links ...directories, aggregators, sub-sub-sub-sub domains from obscure Brazlian domain names and the like. There's so much link "detritus" that keeps coming in when I see latest links on GWT. I think they are simply a victim of their success. The more successful a site is, the more it's on the radar of scrapers / spammers, the more likely it picks up these rubbish automated scrapings. They DO win a lot of useful links too - links that give me genuine referal traffic - perhaps even Google may look at those kinds of links as spam too?
I launched 2 new sites late last year to "replace" these sites - the new sites now outrank the older sites, but the new sites don't really rank anywhere useful for me to make any money. I'm also now reticent to even try to make these a "Google success" - what's the point? It just puts them on the radar of spammers / scrapers. The older sites rank lower than the newer sites, yet the older sites make more money from non-search repeat traffic. An example of the balkanised web here - not visible to Google, but I have my own little "subculture" of customers / visitors who have bookmarked / recommend these sites.
The old sites still rank #1s and #2s in Bing / Yahoo! on popular keywords but that only brings in a small amount of traffic.
I've given up on the concept of launching a site in the hopes Google will love it. As mentioned, when Google do love it, spammers / scrapers come in and tank it. Not really neg-SEO I'm talking about here - I don't mean they do it deliberately - they do it inadvertently. I operate in niches that won't win huge authority links to protect them from these spammy links. I guess I need to go "proactive" to win such authority links....oh but wait, Google don't like guest posts or advertorials....just need to sit and wait... :) - no thanks, Google, there are 500 other things I could be doing to actually bring some money in rather than wait on wishes.


text:
A collection of news and information related to Coughing published by this site and its partners.
Top Coughing Articles
Displaying items 12-22
Top Magic, NBA news, Friday, August 6
Story | Aug 6, 2010 | 4:33 PMBrian Scalabrine, who wants to remain towel-waiver-in-chief on the Boston Celtics bench. We have that story and more in today's links... -
Patent filed by Sony would change the way we play game demos
Story | Mar 23, 2010 | 4:34 PMSiliconera reports that a patent recently filed by Sony could change the way we play game demos. Instead of the standard formula of 'play tiny portion of game' or 'play for X number of days/hours', the actual game play would change based on... -
Islands of Adventure: What's that, Sorting Hat? Read the Harry Potter warning
Paul Klee: Broncos eyeing free agent possibilities . . .
Story | Mar 8, 2014 | 2:05 PMDENVER Codeine cough syrup prevents driving and clear thought. But it has a profound effect on tying flies. So, after a few down days with a cough from hell, my streamer boxes are sufficiently full for April, May and into June's runoff. And now I'm... -
Duke student worked long, hard on the sermon she delivered at campus chapel
Story | Mar 5, 2014 | 9:50 AMDURHAM, N.C. Hannah Ward's first and probably last sermon had been written. And rewritten. And rewritten again, with input from several experts in the Duke Divinity School. She had practiced it in front of a speech professor repeatedly, and alone three... -
Ignoring the flu can be deadly
Story | Mar 4, 2014 | 8:46 AMOn Dec. 20, 2009, 32-year-old actress Brittany Murphy died of flu-related complications in her Beverly Hills, Calif., home. Five months later, her husband, Simon Monjack, was found dead in the same home with the same cause of death: flu-related... -
Surgery can usually treat urinary incontinence, but less invasive options are available
Story | Feb 27, 2014 | 4:30 PMDEAR MAYO CLINIC: I'm 43 and have had trouble with urinary incontinence since having my fourth child at 41. It seemed manageable until about 6 months ago, when I started to notice it happening more frequently. At what point should I consider surgery?... -
The comfortable race traitor
Story | Feb 16, 2014 | 6:36 AMWhen I wrote recently about the multi-lingual Coca-Cola commercial, expressing satisfaction that the influence of white racists appears to be on the wane,* reactions were predictable. A representative specimen from the comment by Blackberry82: "John,... -
Vaccination exemptions still on states' legislative agendas
The Kid's Doctor: Don't get too rattled about your child's health during 'sick season'
Story | Jan 29, 2014 | 2:30 AMPediatric offices are swamped right now! The first months of the new year always mean children have colds, RSV, flu, vomiting, diarrhea, conjunctivitis and strep throat, just to name a few of the illnesses "lurking" around right now. What I don't... -
Got flu? Keep it to yourself.


text:
A collection of news and information related to Sean Weatherspoon published by this site and its partners.
Top Sean Weatherspoon Articles
Displaying items 12-22
Which NFL team is currently the best?
Story | Oct 17, 2012 | 4:03 PMFalcons keep coming Dan Pompei Chicago Tribune If you are looking for the next 1972 Miami Dolphins, you won't find it. That type of team does not exist. Not this year, anyway. Every team will have dips, valleys, slumps and losses. But you have to give... -
Lorenzo Williams and Friends Weekend returns featuring a dozen NFL stars
Scoreboard -- Nov. 2, 2012
Story | Nov 2, 2012 | 10:48 PM|TV SPORTS| |SATURDAY| Soccer--Premier League, Arsenal at Manchester United, 7:30 a.m. (ESPN2); MLS Playoffs, 7 p.m. (NBCSN) College Football--Oklahoma at Iowa State, 11 a.m. (ABC); Texas A&M at Mississippi State, 11 a.m. (ESPN); Temple at Louisville,... -
Scoreboard -- Nov. 3, 2012
Story | Nov 3, 2012 | 10:23 PM|TV SPORTS| |SUNDAY| NFL Football--Denver Broncos at Cincinnati Bengals, Noon (CBS); Minnesota Vikings at Seattle Seahawks, 3 p.m. (FOX); Pittsburgh Steelers at New York Giants, 3:25 p.m. (CBS); Dallas Cowboys at Atlanta Falcons, 7:20 p.m. (NBC)... -
Scoreboard -- Sept. 22, 2012
Story | Sep 22, 2012 | 10:29 PM|TV SPORTS| |SUNDAY| NFL Football--Kansas City Chiefs at New Orleans Saints, Noon (CBS); San Francisco 49ers at Minnesota Vikings, Noon (FOX); Houston Texans at Denver Broncos, 3:25 p.m. (CBS); New England Patriots at Baltimore Ravens, 7:20 p.m. (NBC)... -
Offensive line shows improvement, still has work to do
Story | Aug 18, 2012There was a bit of caution in Marshal Yanda's optimism. Eight days after a mediocre showing in the preseason opener against the Atlanta Falcons, the Ravens offensive line fared much better in the team's 27-12 loss to the Detroit Lions at M&T Bank Stadium... -
O-line improves, still has work to do
Story | Aug 18, 2012There was a bit of caution in Marshal Yanda's optimism. Eight days after a mediocre showing in the preseason opener against the Atlanta Falcons, the Ravens offensive line fared much better in the team's 27-12 loss to the Detroit Lions at M&T Bank Stadium... -
Scoreboard -- Nov. 28, 2012
Story | Nov 28, 2012 | 10:49 PM|TV SPORTS| |THURSDAY| Men's College Basketball — Kentucky at Notre Dame, 6 p.m. (ESPN2); Western Illinois at South Dakota, 7 p.m. (MSN); Marquette at Florida, 8 p.m. (ESPN2). Women's College Basketball — Virginia at... -
Scoreboard -- Nov. 24, 2012
Story | Nov 24, 2012 | 10:36 PM|TV SPORTS| |SUNDAY| Soccer -- Premiere League, Liverpool at Swansea, 7:15 a.m. (ESPN2). National Football League -- Minnesota Vikings at Chicago Bears, noon (FOX); Denver Broncos at Kansas City Chiefs, noon (CBS); San Francisco 49ers at New... -
Scoreboard -- Nov. 9, 2012
Story | Nov 9, 2012 | 11:03 PM|TV SPORTS| |SATURDAY| Soccer--Premier League, 8:55 a.m. (ESPN2); MLS Playoffs, Eastern Conference Championship, First Leg, 2:30 p.m. (NBC) College Football--Arkansas at South Carolina, 11 a.m. (CBS); Iowa State at Texas, 11 a.m. (ABC); Northwestern... -
Scoreboard -- Nov. 10, 2012
Story | Nov 10, 2012 | 10:15 PM|TV SPORTS| |SUNDAY| Tennis--ATP World Tour Finals, 8 a.m., 1:30 p.m. (ESPN2) NFL Football--Denver Broncos at Carolina Panthers, Noon (CBS); Detroit Lions at Minnesota Vikings, Noon (FOX); Dallas Cowboys at Philadelphia Eagles, 3:25 p.m. (FOX); Houston...


text:
Khloe Kardashian has started fertility treatment.
The 27-year-old socialite - who has been married to basketball player Lamar Odom for over two years - reportedly visited the ART Reproductive Center in Beverly Hills on Monday (11.06.12) to discuss her options.
According to gossip website TMZ, Khloe took her sister Kim along for support where she gave blood so that doctors can evaluate her hormone levels and figure out a suitable treatment programme.
Khloe is thought to have been considering getting medical help since her sister Kourtney - who already has a two-year-old son Mason with her boyfriend Scott Disick - announced she is pregnant again and due this summer.
A source said: ''She's thrilled for Kourtney, but she's really sensitive. And it's hard to see your sister get something you want so badly.''
The 'Keeping Up with the Kardashians' star has previously admitted she feels under pressure to have a baby.
Speaking last year, she said: ''People keep saying, 'Why aren't you pregnant yet?' That's what scares me, when people are like, 'Did you go to the doctor? Do you know if everything's working?' It's nerve-racking. Sometimes I feel like I'm letting everyone down.''
Lamar already has two children, Destiny, 13, and 10-year-old Lamar Jr., from a previous relationship.
| Share on Facebook |
- Khloe Kardashian and Lamar Odom announce TV hiatus
- Khloe Kardashian approves of Kim and Kanye
- Kanye West overwhelmed by Kardashian family
- Kanye West gives Kim Kardashian style tips
- Khloe Kardashian wants to dip niece in glitter
- The Kardashian sisters to launch a make-up line


text:
Saturday, 7:30 p.m. Koger Center for the Arts PREMIUM CONCERT
Wagner: Prelude and Liebestod from Tristan und Isolde
R. Strauss: Suite from Der Rosenkavalier
St. Baldrick's currently funds more in childhood cancer research grants than any organization except the U.S. government. The Foundation coordinates its signature head-shaving events worldwide, where volunteers get bald to stand in solidarity with kids fighting cancer and raise money to support life-saving childhood cancer research. St. Baldrick's events are the largest volunteer-driven fundraising opportunity benefitting pediatric cancer research.
Purchase tickets to this and other upcoming events.
Concerts, events, parties, and more.
Ticket sales alone are not enough to keep the orchestra playing.


text:
404 File Not Found
Host by NetBox Version 2.8 Build 4128
Gift Wrap Available
Tetra No More Algae - 8 tablets
Tetra No More Algae leaves aquarium water crystal clear. It works great in glass or acrylic aquariums. Tetra No More Algae removes existing algae from aquarium water and controls the formation of new algae. Not for use with live plants.
Please choose which cart you want to add the item.
By choosing one of the above, you are able to shop for both yourself and a registrant at the same time. Once you are ready to checkout your items will be waiting for you in both your personal and registry shopping carts.
Still need assistance?
Please contact us at 1-866-SHOP-WAG (1-866-746-7924)
Quickly reorder items you've purchased from our Familyhood sites.


text:
-- —
Highlight in History
On Oct. 15, 1917, Dutch dancer Mata Hari, convicted of spying for the Germans, was executed by a French firing squad outside Paris.
On this date
In 1937, the Ernest Hemingway novel "To Have and Have Not" was first published by Charles Scribner's Sons.
In 1945, the former premier of Vichy France, Pierre Laval, was executed for treason.
In 1946, Nazi war criminal Hermann Goering fatally poisoned himself hours before he was to have been executed.
In 1951, the classic sitcom "I Love Lucy" premiered on CBS with the episode "The Girls Want to Go to the Nightclub."
In 1964, it was announced that Soviet leader Nikita S. Khrushchev had been removed from office.
In 1997, British Royal Air Force pilot Andy Green twice drove a jet-powered car in the Nevada desert faster than the speed of sound, officially shattering the world's land-speed record. NASA's plutonium-powered Cassini spacecraft rocketed flawlessly toward Saturn.
Ten years ago
Eleven people were killed when a Staten Island ferry slammed into a maintenance pier. (The ferry's pilot, who'd blacked out at the controls, later pleaded guilty to 11 counts of manslaughter.) Doctors in Florida removed the feeding tube of Terri Schiavo, a severely brain-damaged woman at the center of a right-to-die battle. (The tube was reinserted, then removed again, as the legal battle played out, ending with Schiavo's death in March 2005.) An explosion ripped apart a U.S. diplomatic vehicle in the Gaza Strip, killing three Americans. China launched its first manned space mission. The Florida Marlins won the National League championship with a 9-6 victory over the Chicago Cubs in Game 7.
Five years ago
Republican John McCain repeatedly assailed Democrat Barack Obama's character and campaign positions on taxes, abortion and more in a debate at Hofstra University; Obama parried each accusation, and leveled a few of his own, saying "100 percent" of McCain's campaign ads were negative. The Philadelphia Phillies beat the Los Angeles Dodgers 5-1 to win the NL championship series 4-1 for its first pennant since 1993. Pop star Madonna and movie director Guy Ritchie announced they were divorcing after nearly eight years of marriage. Actress-singer Edie Adams died in Los Angeles at age 81. Longtime game show host Jack Narz died in Los Angeles at age 85.
One year ago
In interviews with CNN and Fox News, Secretary of State Hillary Rodham Clinton took responsibility for security at the U.S. consulate in Libya, where the U.S. ambassador and three other Americans were killed in a Sept. 11, 2012, attack.
National, International News
Today in History for Tuesday, Oct. 15, 2013
- National, International News
Malaysia loses contact with plane carrying 239
Malaysia Airlines said Saturday it lost contact with a plane carrying 239 people on its way from Kuala Lumpur to Beijing and search and rescue teams were trying to locate the aircraft.
Four dead in New Jersey fire; mix-up delayed response
A fast-moving fire claimed four lives on Thursday in New Jersey's second-largest city, where the mayor said a mix-up over the street name delayed the emergency response.
Crimea to vote to split from Ukraine, join Russia
Ukraine lurched toward breakup Thursday as lawmakers in Crimea unanimously declared they wanted to join Russia and would put the decision to voters in 10 days. President Barack Obama condemned the move and the West answered with the first real sanctions against Russia.
Today in History for Friday, March 7, 2014
Today is Friday, March 7, the 66th day of 2014. There are 299 days left in the year.
Harsh U.S. winter extends into March
On the latest snow day in a winter full of them, residents of parts of the South, Mid-Atlantic and Northeast were coping with several inches of snow on top of a layer of slush.
Today in History for Tuesday, March 4, 2014
Today is Tuesday, March 4, the 63rd day of 2014. There are 302 days left in the year.
World scrambles as Russia tightens grip on Crimea
Warning that it was "on the brink of disaster," Ukraine put its military on high alert Sunday and appealed for international help to avoid what it feared was the possibility of a wider invasion by Russia.
High court looks at death row inmate with low IQ
A Floridian with an IQ as high as 75 may be diagnosed as mentally disabled and be eligible for help getting a job. But on death row, the state says having an IQ higher than 70 categorically means an inmate is not mentally disabled and may be executed.
Today in History for Monday, March 3, 2014
Today is Monday, March 3, the 62nd day of 2014. There are 303 days left in the year.
'12 Years a Slave' wins best picture at Oscars
Perhaps atoning for past sins, Hollywood named the brutal, unshrinking historical drama "12 Years a Slave" best picture at the 86th annual Academy Awards.
- More National, International News Headlines
Malaysia loses contact with plane carrying 239


text:
(#1 in Explore and Front Page)
This shot was taken in a cave in Vietnam. (I can't remember the name but it's somewhere in Halong Bay) When I turned the corner and saw these rays I almost dropped my camera in amazement. These are by far the strongest rays of light I have ever seen. I spent quite a while deciding on the comp for this, and I think I'm happy with it. Let me know what you think.
Thanks for stopping in!!
Not HDR.
MBesantPhoto, karma (Karen), and 974 other people added this photo to their favorites.
Wow! Love the lighting! Great composition too!
Perfect moment !!!
Great Great Pic !
Really impressed by your talent. By the way, I haven't checked every single comment but i'm pretty sure the name of the cave is Sung Sot Cave (Cave of Surprises). I was there like a month ago :) -
this is really a one of a kind shot, great job.
Free Shipping Brainetics Secrets 40% OFF For Sale
100% original! Free Shipping! 40$ OFF! Best Servces! Paypal!
www.mathfeats.combrainetics,brainetics secrets,brainetics discount,brainetics wholesale
brainetics playbook,brainetics workbook,brainetics wiki
brainetics wholesale
brainetics scam
brainetics reviews
brainetics tricks
brainetics download
cheap brainetics
discount brainetics
china brainetics
brainetics math
brainetics playbook
brainetics youtube
brainetics sale
brainetics 2020
brainetics dvd
brainetics math tricks
brainetics cheap
brainetics china
brainetics discount
brainetics reviews
brainetics scam
does brainetics work
brainetics llc
brainetics for adilts
brainetics program
buy brainetics
discount brainetics
brainetics us
brainetics wiki
brainetics outlet
brainetics playbook
mike byster -
Wow. Simply amazing tonality ... have to say that everytime I see your stuff!
heavenly light. Amazing tones. wonderful.
great shot! Ive been in that cave too!
Fantastic shot!
-When nature decided to give you a rare show like this, you better be ready,and apparently you were, great technique here.
Wonderful image!
i absolutely like the title that you gave to the photo i also like the light and the b&w ... :)
I think it's absolutely magical! What good karma you must have to be so blessed with capturing such an incredible image! Now a favourite - with thanks and appreciation!
superb bw and light here
daaaaaaaaaaaaamn. Rays for days
Great shot !
Seen in La Crème de la Crème -
I think the comp is spot on ....Beautifuly captured !
nice,ilove it


text:
Joined: 29 May 2005
Posts: 3786
| |
Amit Sadh |
Action adventure
I have always been very choosy about the work I take on. Guns N Roses went off air over a month ago, but I didn't get panicky or insecure about not knowing what to do next. I waited for the right shows to come my way.
I will be doing a show on Sahara One; it is an action adventure show set in the heart of the city. It has elements of reality in it. My second show is on Sony, where I play one of three sons.
Kirron Kher is my mother and it revolves around my relationship with her and my brothers. In the past, I have been offered lots of melodramatic, stereotypical roles, but always resisted doing them. I don't like too much drama; I choose things that really excite me.
On not being paid by his ex-producer
I had a great time doing Guns N Roses � that's where I met Neeru, so I am grateful for the show.
But I didn't share a healthy relationship with my producer, Shrishti Behl Arya. After giving everything to that show, in the end, I was treated disrespectfully.
Apparently, Shrishti is telling other producers not to give Neeru and me work. I have learnt that she is sending them messages asking them to stay away from me, saying I am a troublemaker. Even Goldie Behl had issues with me when Neeru and I started living together.
He would ask me why we were staying under the same roof, when it was none of his business. I have not been paid for the show after it ended.
There are many other actors that Shrishti's production house, Rose Audio Visuals, hasn't paid. When I checked with Shrishti, she said Star One has no money to pay you guys.
Neeru and I know in what conditions we worked for the show. But I ignored everything, because I always like to look at the positive side. In the past, I have had creative differences with Ekta Kapoor as well; but when it came to payment, there was no one as professional as her.
Even though I left her show, she paid me every bit for my work. Thankfully, my relations with my other producers are solid. They trust me and know what I am worth.
On marriage to Neeru Bajwa
The day I proposed to Neeru, I told her I wanted to spend the rest of my life with her. She's the best thing to have happened to me. As I said, had it not been for Guns N Roses, I may have not have met her. We are living together right now, and plan to tie the knot very soon.
Joined: 16 June 2004
Posts: 3193
thanx !!!!!!
why does this guy have problem with most of the producers ?
Joined: 29 May 2005
Posts: 3786
Topics | Topic Starter | Replies | Views | Last Post | |
Guns n Roses | ucandoit | 4 | 1322 | 29 June 2006 at 6:35am By janhvi_janu |
Liked guns and roses | AryanDipikaFan | 3 | 514 | 21 November 2005 at 9:54am By -.nandini.- |
Guns & Roses | avidwatcher1 | 12 | 1347 | 16 November 2005 at 1:41am By AryanDipikaFan |
Do you remember Family..&Guns.. | HUMM | 12 | 1182 | 20 June 2005 at 11:49am By annwesha |
Gun's nd Roses | pranx | 6 | 856 | 20 June 2005 at 11:45am By annwesha |


text:
Canning Supplies Starting At $4.99!
The canning season is already upon us!
You can find some really cute canning supplies on sale today with prices starting at just $4.99. This sale includes everything you need as well as some things you might not but are just too cute to pass up.
How to find the sale:
If you are new to Zulily Click on this special invite link to join (it's free).


text:
What's that outside my window?
25 03 2011Ok what's the date today? Right, it's March 25. That means we are technically five days into Spring.
With this all in mind, I would like to know what game Toronto is playing?!!
Sure it's Friday and usually I try to find a photo of the day that will inspire travel or highlight another culture, but today it's about recognizing that travel is not always fun.
Nope. Not when you're sitting in Bermuda's L.F. Wade Airport for an extra three to four hours because of your plane's delay. Not when you're forced to listen to a steward who thinks he's funny for endless hours on the plane.
"What do you call a fish with no eyes????………A fsh."
Traveling is definitely not fun when you land in Toronto at 1.30 a.m. (Bermuda time) and have to wait half an hour for your bag, while needing a toilet.
And traveling just gets plain interesting when you have to exit the airport into negative degree temperature and snow covering the ground.
Good thing there are good people here or traveling would just be tiring today! And of course that brings us back to our photo of the day: snow from my window! Have a good one.